Therapeutic plasma exchange to slow cognitive decline in Alzheimer’s disease

Dementia specialists Mercè Boada, MD, PhD, Fundació ACE, International University of Catalonia, Barcelona, Spain; Javier Olazarán, MD, PhD, Gregorio Marañón Hospital, Madrid, Spain; and Miquel Lozano, MD, PhD, Hospital Clínic de Barcelona, Barcelona, Spain, discuss the use of plasma exchange plus albumin replacement as an innovative treatment for Alzheimer´s disease, from rationale through to Phase III data and clinical implementation.